Altered muscle transcriptome as molecular basis of long-term muscle weakness in survivors from critical illness
Intensive Care Medicine · 2025-06 · 51 (6) · 1062-1077
DOI: 10.1007/s00134-025-07949-3 ↗Kurz gefasst
Klinische Studie (Phase IV) in der Zeitschrift Intensive Care Medicine, online erschienen am 10.06.2025. Verfasst von Ceren Uzun Ayar und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Critical Illness, Muscle Weakness, Muscle, Skeletal, Survivors. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Methusalem program of the Flemish government, FP7 Ideas: European Research Council, H2020 European Research Council.
Abstract (Originalsprache)
PURPOSE: Critically ill patients requiring intensive care unit (ICU) admission suffer from muscle weakness that persists for years, compromising quality-of-life. The pathophysiology of this long-term weakness remains unclear. We hypothesized that former ICU-patients show a long-term abnormal RNA-expression profile, which may contribute to lower long-term strength and for which modifiable risk factors can be identified. METHODS: This pre-planned secondary analysis of the EPaNIC-trial compared muscle transcriptomes of 115 former ICU-patients 5 years after critical illness and 30 matched controls with RNA-sequencing, followed by pathway over-representation and differential co-expression analyses of the differentially expressed RNAs. We used multivariable linear regression analyses to identify which of the abnormal RNA-expressions associated with the long-term muscle strength of the patients and to identify potential risk factors for the abnormal RNA-expressions. RESULTS: In former patients, 234 down-regulated and 116 up-regulated RNAs were identified after adjustment for age, sex, and BMI. Pathway over-representation and further molecular and histological analyses indicated impaired mitochondrial energy metabolism, disturbed lipid metabolism, and increased collagen formation/fibrosis in former patients. Abnormal muscle RNA-expression in former patients correlated with lower long-term muscle strength. Several treatments given in-ICU and at 5-year follow-up associated with abnormal RNA-expression, most notably in-ICU early parenteral nutrition (early PN) and glucocorticoid use. CONCLUSION: Abnormal RNA-expression profiles 5 years after critical illness suggest disrupted mitochondrial function, disturbed lipid metabolism, and fibrosis, associated with lower long-term muscle strength and partly attributable to possibly avoidable risk factors. These findings open perspectives for prevention and possibly treatment of long-term muscle weakness after critical illness. TRIAL REGISTRATION NUMBER AND DATE: ClinicalTrials.gov-NCT00512122, July 31, 2007.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
- Clinical Division of Intensive Care Medicine, University Hospitals Leuven, Leuven, Belgium.
- Laboratory of Cell Biology and Histology, University of Antwerp, Antwerp, Belgium.
- Antwerp Center for Advanced Microscopy (ACAM), University of Antwerp, Wilrijk, Belgium.
- Medical Intensive Care Unit, Department of General Internal Medicine, University Hospitals Leuven, Leuven, Belgium.
- Department of Medicine and Institute of Medical Biotechnology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
ORCID-Profile: Ceren Uzun Ayar, Fabian Güiza, Isabel Pintelon, Michaël Casaer, Nathalie Van Aerde, Greet Hermans, Sarah Derde, Lucas Kreiss, Greet Van den Berghe, Ilse Vanhorebeek
Förderung
- Methusalem program of the Flemish government
- FP7 Ideas: European Research Council
- H2020 European Research Council
- HORIZON EUROPE European Research Council
- Research Foundation-Flanders
- Research Foundation Flanders-
- KU Leuven
Zitieren
APA
Uzun Ayar, C., Güiza, F., Derese, I., Pauwels, L., Vander Perre, S., Pintelon, I., Casaer, M., Van Aerde, N., Hermans, G., Derde, S., Kreiss, L., Van den Berghe, G., & Vanhorebeek, I. (2025). Altered muscle transcriptome as molecular basis of long-term muscle weakness in survivors from critical illness. Intensive Care Medicine, 51(6), 1062-1077. https://doi.org/10.1007/s00134-025-07949-3
Vancouver
Uzun Ayar C, Güiza F, Derese I, Pauwels L, Vander Perre S, Pintelon I, et al. Altered muscle transcriptome as molecular basis of long-term muscle weakness in survivors from critical illness. Intensive Care Medicine. 2025;51(6):1062-1077. doi:10.1007/s00134-025-07949-3
BibTeX
@article{UzunAyar2025,
author = {Uzun Ayar, Ceren and Güiza, Fabian and Derese, Inge and Pauwels, Lies and Vander Perre, Sarah and Pintelon, Isabel and Casaer, Michaël and Van Aerde, Nathalie and Hermans, Greet and Derde, Sarah and Kreiss, Lucas and Van den Berghe, Greet and Vanhorebeek, Ilse},
title = {Altered muscle transcriptome as molecular basis of long-term muscle weakness in survivors from critical illness},
journal = {Intensive Care Medicine},
year = {2025},
volume = {51},
number = {6},
pages = {1062--1077},
doi = {10.1007/s00134-025-07949-3}
}
EUVIMED